Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
Are there any recommendations for restarting JAKi after a provoked DVT?
Related Questions
What is your approach to assessing inflammatory arthritis flares in joints that have been replaced (such as knees)?
How do you manage a patient with severe RA or SLE that worsens after stopping immunosuppressants due to having chronic foot ulceration?
How do you approach treatment of a patient with active RA and a history of Lynch Syndrome?
Do you feel comfortable using Jak inhibitors in patients with a strong family history of CAD, but no other risk factors?
How do you approach monitoring when using combination JAK inhibitors and methotrexate in RA?
How do you approach managing nausea and GI side effects when initiating methotrexate?
Are you comfortable with using NSAIDs in a patient on methotrexate for inflammatory arthritis?
Would you consider adding dupilumab to adalimumab (or other monoclonal antibodies) in a patient who has RA and refractory atopic dermatitis and already is on MTX 25 mg weekly?
If subdeltoid bursitis, bicipital tenosynovitis, and femoroacetabular synovitis are commonly present in PMR, why are they not included in the criteria for PMR and how are they differentiated from elderly onset RA where presentation is often atypical and more proximal?
Are you comfortable trying a different JAK inhibitor in patients with prior JAK inhibitor allergy?
